Cardiomyopathies and Heart Failure: Biomolecular, Infectious and Immune Mechanisms

537 Pages·2003·25.22 MB·English

by  Akira Matsumori MD

CARDIOMYOPATHIES AND HEART
FAILURE: BIOMOLECULAR,
INFECTIOUS AND IMMUNE
MECHANISMS
Developments in Cardiovascular Medicine
232. A. Bay es de Luna, F. Furlanello, B.J. Maron and D.P. Zipes (eds.):
Arrhythmias and Sudden Death in Athletes. 2000 ISBN: 0-7923-6337-X
233. J-C. Tardif and M.G. Bourassa (eds): Antioxidants and Cardiovascular Disease.
2000. ISBN: 0-7923-7829-6
234. J. Candell-Riera, J. Castell-Conesa, S. Aguade Bruiz (eds): Myocardium at
Risk and Viable Myocardium Evaluation by SPET. 2000.ISBN: 0-7923-6724-3
235. M.H. Ellestad and E. Amsterdam (eds): Exercise Testing: New Concepts for the
New Century. 2001. ISBN: 0-7923-7378-2
236. Douglas L. Mann (ed.): The Role of Inflammatory Mediators in the Failing
Heart. 2001 ISBN: 0-7923-7381-2
237. Donald M. Bers (ed.): Excitation-Contraction Coupling and Cardiac
Contractile Force, Second Edition. 2001 ISBN: 0-7923-7157-7
238. Brian D. Hoit, Richard A. Walsh (eds.): Cardiovascular Physiology in the
Genetically Engineered Mouse, Second Edition. 2001 ISBN 0-7923-7536-X
239. Pieter A. Doevendans, A. A.M. Wilde (eds.): Cardiovascular Genetics for Clinicians
2001 ISBN 1-4020-0097-9
240. Stephen M. Factor, Maria A.Lamberti-Abadi, Jacobo Abadi (eds.): Handbook of
Pathology and Pathophysiology of Cardiovascular Disease. 2001
ISBN 0-7923-7542-4
241. Liong Bing Liem, Eugene Downar (eds): Progress in Catheter Ablation. 2001
ISBN 1-4020-0147-9
242. Pieter A. Doevendans, Stefan Kääb (eds): Cardiovascular Genomics: New
Pathophysiological Concepts. 2002 ISBN 1-4020-7022-5
243. Daan Kromhout, Alessandro Menotti, Henry Blackburn (eds.): Prevention
of Coronary Heart Disease: Diet, Lifestyle and Risk Factors in the Seven
Countries Study. 2002 ISBN 1-4020-7123-X
244. Antonio Pacifico (ed.), Philip D. Henry, Gust H. Bardy, Martin Borggrefe,
Francis E. Marchlinski, Andrea Natale, Bruce L. Wilkoff (assoc. eds):
Implantable Defibrillator Therapy: A Clinical Guide. 2002
ISBN 1-4020-7143-4
245. Hein J.J. Wellens, Anton P.M. Gorgels, Pieter A. Doevendans (eds.):
The ECG in Acute Myocardial Infarction and Unstable Angina: Diagnosis and Risk
Stratification. 2002 ISBN 1-4020-7214-7
246. Jack Rychik, Gil Wernovsky (eds.): Hypoplastic Left Heart Syndrome. 2003
ISBN 1-4020-7319-4
247. Thomas H. Marwick: Stress Echocardiography. Its Role in the Diagnosis and
Evaluation of Coronary Artery Disease 2nd Edition. 2003
ISBN 1-4020-7369-0
248. Akira Matsumori: Cardiomyopathies and Heart Failure: Biomolecular, Infectious
and Immune Mechanisms. 2003 ISBN 1-4020-7438-7
Previous volumes are still available
CARDIOMYOPATHIES AND HEART
FAILURE: BIOMOLECULAR,
INFECTIOUS AND IMMUNE
MECHANISMS
edited by
Akira Matsumori, MD, PhD
Department of Cardiovascular Medicine
Kyoto University Graduate School of Medicine
Kyoto, Japan
SPRINGER SCIENCE+BUSINESS MEDIA, LLC
Library of Congress Cataloging-in-Publication Data
Cardiomyopathies and heart failure : biomolecular, infectious, and immune mechanisms /
edited by Akira Matsumori
p. ; cm. - (Developments in cardiovascular medicine ; v. 248)
Includes bibliographical references and index.
ISBN 978-1-4613-4865-8 ISBN 978-1-4419-9264-2 (eBook)
DOI 10.1007/978-1-4419-9264-2
1. Myocardium—Pathophysiology. 2. Myocardium—Diseases—Molecular aspects. 3.
Myocardium—Diseases—Immunological aspects. 4. Heart failure—Pathophysiology.5.
Heart failure—Molecular aspects. 6. Heart failure—Immunological aspects. I. Matsumori, Akira,
1946- II. Series.
[DNLM: 1. Myocardial Diseases—immunology. 2. Heart Failure, Congestive—etiology.
3.Heart Failure, Congestive—immunology. 4. Heart Failure, Congestive—therapy. 5.
Myocardial Diseases—etiology, 6. Myocardial Diseases—therapy. WG 280 C26668 2003]
RC685.M9C3545 2003
616.1'2407—dc21
Copyright © 2003 Springer Science+Business Media New York
Originally published by Kluwer Academic Publisher, New York in 2003
Softcover reprint of the hardcover 1st edition 2003
All rights reserved. No part of this work may be reproduced, stored in a retrieval
system, or transmitted in any form or by any means, electronic, mechanical,
photocopying, microfilming, recording, or otherwise, without the written permission
from the Publisher, with the exception of any material supplied specifically for the
purpose of being entered and executed on a computer system, for exclusive use by the
purchaser of the work
Permission for books published in Europe: [email protected]
Permissions for books published in the United States of America: [email protected]
Printed on acid-free paper.
CONTENTS
CONTRIBUTORS xi
PREFACE xxi
1 INTRODUCTORYCHAPTER
CARDIOMYOPATHIESANDHEART FAILURE
Biomolecular, Infectiousand ImmuneMechanisms
AkiraMatsumori , 1
II. CYTOKINES INCARDIOMYOPATHIESAND
HEART FAILURE
1. CHEMOKINESAND CARDIOVASCULARDISEASES
Kouji Matsushima, Yuya Terashima, Hiroyuki Yoneyama, Makoto
Haino 17
2. NEGATIVE REGULATOR OF CYTOKINE SIGNALING
(SOCS) GENES IN INFLAMMATION
IchikoKinjyo, Hideo Yasukawa, Akihiko yoshimura 27
3. THE INTERLEUKIN-6 FAMILY OF CYTOKINES AND
THEIR RECEPTORS IN PATIENTS WITH CONGESTIVE
HEART FAILURE
Keiko Yamauchi-Takihara, Hisao Hirota, Masahiro Izumi,. Shoko
Sugiyama,Tomoyuki Hamaguchi. 39
4. ANIMAL MODEL OF CARDIOMYOPATHY DUE TO
OVEREXPRESSION OFTNF-a
TOfUKubota .47
vi CONTENTS
III. AUTOIMMUNITY INCARDIOMYOPATHIES
AND HEARTFAILURE
5. MYOSIN AUTOREACTIVE T CELLS AND AUTOIMMUNE
MYOCARDITIS: LESSONS FROM THE DISEASE CAUSED
BYCARDIACMYOSIN PEPTIDECM2
Tohru Izumi, Hitoshi Takehana, Ken Kohno, Mototsugu Nishi, Ichiro
Takeuchi, Hironari Nakano, Toshimi Koitabashi, Takayuki Inomata
..................................................................................59
6. AUTOIMMUNITYINCARDIOMYOPATHIES
Michel Noutsias, Matthias Pauschinger, Uwe Kiihl, Heinz-Peter
Schultheiss 67
7. ANTI-G-PROTEIN COUPLED CARDIAC RECEPTOR
AUTOANTIBODIES INDILATEDCARDIOMYOPATHY
Michael Fu 83
8. CLINICAL SIGNIFICANCE OF CIRCULATING CARDIAC
AUTOANTIBODIES IN DILATED CARDIOMYOPATHY AND
MYOCARDITIS
AlidaLPCaforio, WilliamJMcKenna 97
IV. MASTCELLMEDIATORSAND HUMAN
DISEASES: BASICASPECTS
9. DEVELOPMENT OF MAST CELLS: PROCESS AND
REGULATORY MECHANISMS
YukihikoKitamura, Eiichi Morii,TomokoJippo, AkihikoIto....111
10. MAST CELLS IN EXPERIMENTAL MYOCARDIAL
INFARCTION
NikolaosG Frangogiannisand MarkL Entman 121
CONTENTS vii
11. POSSIBLE INVOLVEMENT OF MAST CELLS IN THE
DEVELOPMENTOFFIBROSIS
Motohiro Kurosawa, PharAkira Okano, Masatoshi Abe, Osamu
Ishikawa, NaotomoKanbe, and Yoshiki Miyachi 133
12. HUMAN MAST CELL CHYMASE AND 31 AMINO ACID
ENDOTHELIN-1
Hiroshi Kido, Ping Cui, Saimoon Sharmin, Mayumi Shiota, DengFu
Yao,ChunxingLin, Mihiro Yano 145
13. TRYPTASE FROMHUMANMAST CELLS
LawrenceB.Schwartz 159
14. EFFECTS OF THE TRYPTASE RECEPTOR ACTIVATING
PEPTIDE AND ANTIBODIES AGAINST THE TRYPTASE
RECEPTOR PAR-2 ON NEONATAL RAT
CARDIOMYOCYTESINCULTURE
Gerd Wallukat, Rosemarie Morwinski, Eberhard Nissen, Johannes
MUlier,FriedrichC. Luft 173
V. MASTCELLMEDIATORSAND HUMAN
DISEASES CLINICALASPECTS
15. ROLE OF HUMAN HEART MAST CELLS IN
IMMUNOLOGIC AND INFLAMMATORY MECHANISMS
UNDERLYING CARDIOVASCULARDISORDERS
Gianni Marone, Francescopaolo Granata, Virginia Forte, Ersilia Di
Maro,EloisaAIbustini, ArturoGenovese .185
16. MAST CELLS IN ATHEROSCLEROTIC HUMAN
CORONARY ARTERIES: IMPLICATIONS FOR CORONARY
FATTY STREAK FORMATION AND PLAQUE EROSION OR
RUPTURE
PetriTKovanen, Miriam Lee, Ken ALindstedt.. 199
17. THE KEY ROLE OF MAST CELLS IN THE EVOLUTION TO
CONGESTIVEHEARTFAILURE
MasatakeRara, Koh Ono,ShigetakeSasayama,AkiraMatsumori...213
viii CONTENTS
VI. VIRALETIOLOGYOFCARDIOMYOPATHIES
AND HEARTFAILURE
18. LINKS BETWEEN VIRAL INFECTIONS AND HEART
DISEASE
CharlesJGauntt, RichardMontellano,Timothy ASkogg 229
19. MOLECULAR DETECTION AND CHARACTERIZATION OF
HUMAN ENTEROVIRUSES
Mark APallansch, MStevenOberste 245
20. DETECTION AND BIOLOGICAL IMPLICATIONS OF
GENETIC MEMORYINVIRALQUASISPECIES
EstebanDomingo,CannenM. Ruiz-Jarabo, ArmandoArias,Cannen
Molina-Paris,Carlos Briones,EricBaranowski,CristinaEscannis....259
21. THE GROUP B COXSACKIEVIRUSES AS VACCINES AND
VECTORS
NoraMChapman, K-S Kim, StevenTracy 277
22. DETECTION OF IMPORTANT DIAGNOSTIC MARKERS OF
HCVINFECTION
Howard A. Fields 291
VII. DIAGNOSISANDTREATMENTOFMYOCARDITIS
23. LARGE ANIMAL MODELOFVIRALMYOCARDITIS
MKNjenga, AMatsumori, JKGwathmey 301
24. HEPATITIS CVIRUSANDCARDIOMYOPATHY
Yukihito Sato, TasukuYamada, AkiraMatsumori 325
25. DIAGNOSISANDTREATMENTOFMYOCARDITIS: THE
ROLE OFADENOVIRUS INFECTION IN
CARDIOMYOPATHYAND HEARTFAILURE
Jeffrey ATowbin,Neil EBowles 341
CONTENTS ix
26. THE NATURAL HISTORY OF VIRAL MYOCARDITIS:
PATHOGENETIC ROLE OF ADRENERGIC SYSTEM
DYSFUNCTION IN THE DEVELOPMENT OF IDIOPATHIC
DILATED CARDIOMYOPATHY
Petar M. Seferovic, Arsen D. Ristic, Rucica Maksimovic, Dejan
Simeunovic, DanijelaTrifunovic 357
27. CLINICALDIAGNOSISOF MYOCARDITIS
G William Dec 373
28. RECENTADVANCES INGIANTCELL MYOCARDITIS
LeslieTCooper, Jr 389
29. REGISTRYOFMYOCARDITISANDHEARTFAILURE
MinNian, AnneOpavsky, Malcolm Arnold, PeterLiu .401
VIII. MOLECULARANDGENETIC ANALYSES
IN HEARTDISEASE
30. MOLECULAR ETIOLOGY OF IDIOPATHIC
CARDIOMYOPATHY
Akinori Kimura, Takeharu Hayashi, Manatsu Itoh-Satoh, Takuro
Arimura, DVS, Won-Ha Lee, Su Yeoun Lee,Jeong-Euy Park ...415
31. GENE-BASEDTHERAPYOFLONGQTSYNDROME
Jay WMason 429
IX. THE FUTURE INTHEMANAGEMENT
OFCARDIOMYOPATHIESAND HEARTFAILURE
32. HOWDOESADENOSINE MEDIATE CARDIOPROTECTION?
Masafumi Kitakaze, Jiyoong Kim, Hitonobu Tomoike, Soichiro
Kitamura 439
33. PROTECTION OFCELL INJURYBYTHIOREDOXIN
Keisuke Shioji, Hajime Nakamura, Chiharu Kishimoto, Zuyi Yuan,
Junji Yodoi 457
x CONTENTS
34. HEMATOPOIETIC STEMCELLSAND ANGIOGENESIS
Nobuyuki Takakura .469
35. TRANSPLANTING CELLS FOR THE TREATMENT OF
CARDIOMYOPATHY
Keiichi Tambara, Yutaka Sakakibara, Takeshi Nishina, Takuya
Nomoto, Lu Fanglin, Tadashi Ikeda, Kazunobu Nishimura, Masashi
Komeda 481
36. TOWARD AN IDEAL LARGE ANIMAL MODEL OF
DILATED CARDIOMYOPATHY TO STUDY LEFT
VENTRICULARVOLUMEREDUCTION SURGERY
Tadaaki Koyama, Kazunobu Nishimura, Takeshi Nishina, Senri
Miwa, Yoshiharu Soga, Oriyanhan Unimonh, Koji Ueyama, Taiko
Horii, Masashi Komeda .491
37. HEARTTRANSPLANTATION: 35YEARSOFPROGRESS
RichardJRodeheffer 503
38. GENES OF THE MAJOR HISTOCOMPABILITY COMPLEX
CLASS II INFLUENCE THE PHENOTYPE OF
CARDIOMYOPATHIES ASSOCIATED WITH HEPATITIS C
VIRUS INFECTION
Akira Matsumori, Naohiro Ohashi, Haruyasu Ito, Yutaka Furukawa,
PhD; Koji Hasegawa, Shigetake Sasayama, Taeko Naruse; and
Hidetoshi Inoko, andco-investigators 515
INDEX 523